Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Chubb
Queensland Health
Fish and Richardson
Covington
Mallinckrodt
Citi
Cantor Fitzgerald
Baxter
Fuji

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076790

« Back to Dashboard

NDA 076790 describes CICLOPIROX, which is a drug marketed by Fougera Pharms, G And W Labs Inc, Glenmark Pharms, Perrigo New York, Taro, Cnty Line Pharms, Glenmark Generics, Paddock Llc, Actavis Mid Atlantic, Perrigo Co, Akorn, Apotex Inc, Cipla Ltd, G And W Labs, Hi Tech Pharma, Mylan Pharms Inc, Taro Pharm Inds, Teva Pharms, and Tolmar, and is included in twenty-seven NDAs. It is available from nineteen suppliers. There are two patents protecting this drug. Additional details are available on the CICLOPIROX profile page.

The generic ingredient in CICLOPIROX is ciclopirox. There are ten drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ciclopirox profile page.
Summary for 076790
Tradename:CICLOPIROX
Applicant:Taro
Ingredient:ciclopirox
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 076790
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CICLOPIROX ciclopirox CREAM;TOPICAL 076790 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1318 51672-1318-2 1 TUBE in 1 CARTON (51672-1318-2) > 30 g in 1 TUBE
CICLOPIROX ciclopirox CREAM;TOPICAL 076790 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1318 51672-1318-8 1 TUBE in 1 CARTON (51672-1318-8) > 90 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.77%
Approval Date:Apr 12, 2005TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Julphar
US Department of Justice
Express Scripts
Johnson and Johnson
Merck
Healthtrust
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot